Mice With Targeted Deletion of Receptor for Hyaluronan-Mediated Motility (RHAMM, CD168) Are Protected From Bleomycin-Induced Lung Injury

被引：0
|
作者：
Savani, Rashmin C. [1 ]
Cheong, Naeun [1 ]
Mitchell, Jason [1 ]
Al-Saadi, Rajiha [1 ]
Liao, Jie [1 ]
机构：
[1] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
来源：
FASEB JOURNAL | 2010年 / 24卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：1
相关论文
共 46 条
  • [21] Mice lacking the receptor-like protein tyrosine phosphatase CD148 are protected from bleomycin-induced pulmonary fibrosis
    Katsumoto, Tamiko R.
    Kim, Kevin K.
    Brumwell, Alexis N.
    Nguyen, John X.
    Zhu, Jing W.
    Looney, Mark R.
    Chapman, Harold A.
    Weiss, Arthur
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (05) : S67 - S67
  • [22] Mice Lacking the Receptor-Like Protein Tyrosine Phosphatase CD148 Are Protected From Bleomycin-Induced Pulmonary Fibrosis
    Katsumoto, Tamiko R.
    Kim, Kevin K.
    Brumwell, Alexis N.
    Nguyen, John X.
    Rosen, Connor E.
    Callahan, Elliott
    Zhu, Jing W.
    Looney, Mark R.
    Chapman, Harold A.
    Weiss, Arthur
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S580 - S580
  • [23] Deletion Of HIF-1Alpha From Mouse Lung Epithelial Cells Exacerbates Bleomycin-Induced Lung Injury
    Shannon, J. M.
    Young, L. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [24] Identification and characterization of epitopes of the receptor for hyaluronic acid-mediated motility (RHAMM/CD168) recognized by CD8+ T cells of HLA-A2-positive patients with acute myeloid leukemia
    Greiner, J
    Li, L
    Ringhoffer, M
    Barth, TFE
    Giannopoulos, K
    Guillaume, P
    Ritter, G
    Wiesneth, M
    Döhner, H
    Schmitt, M
    BLOOD, 2005, 106 (03) : 938 - 945
  • [25] Antileukinate, a Hexapeptide Inhibitor of CXC-Chemokine Receptor, Suppresses Bleomycin-induced Acute Lung Injury in Mice
    S. Hayashi
    J. Yatsunami
    Y. Fukuno
    M. Kawashima
    E. J. Miller
    Lung, 2002, 180 : 339 - 348
  • [26] Antileukinate, a hexapeptide inhibitor of CXC-chemokine receptor, suppresses bleomycin-induced acute lung injury in mice
    Hayashi, S
    Yatsunami, J
    Fukuno, Y
    Kawashima, M
    Miller, EJ
    LUNG, 2002, 180 (06) : 339 - 348
  • [27] Transglutaminase 2 knockout mice are protected from bleomycin-induced lung fibrosis with preserved lung function and reduced metabolic derangements
    Freeberg, Margaret A. T.
    Thatcher, Thomas H.
    Camus, Sarah V.
    Huang, Linghong
    Atkinson, John
    Narrow, Wade
    Haak, Jeannie
    Dylag, Andrew M.
    Cowart, L. Ashley
    Johnson, Timothy S.
    Sime, Patricia J.
    PHYSIOLOGICAL REPORTS, 2024, 12 (12):
  • [28] Prognostic significance of receptor for hyaluronan acid-mediated motility (CD168) in acute pediatric leukemias - assessment of clinical outcome, post induction, end of treatment and minimal residual disease
    Shalini, Chinnathambi Narayanan Sai
    Suman, Febe Renjitha
    Jacob, Jerusha Samuela
    Rajendran, Rithika
    Scott, Julius Xavier
    Latha, Magadha Sneha
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2018, 40 (04) : 310 - 316
  • [29] Lysophosphatidic Acid Receptor-2 Deficiency Confers Protection against Bleomycin-Induced Lung Injury and Fibrosis in Mice
    Huang, Long Shuang
    Fu, Panfeng
    Patel, Priya
    Harijith, Anantha
    Sun, Tianjiao
    Zhao, Yutong
    Garcia, Joe G. N.
    Chun, Jerold
    Natarajan, Viswanathan
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2013, 49 (06) : 912 - 922
  • [30] Directed gp130-Mediated Signaling Dissociates Inflammation from Fibrosis in Bleomycin-Induced Lung Injury
    O'Donoghue, Robert J. J.
    PAnderson, Gary
    Bozinovski, Steven
    Jones, Jessica
    Ernst, Matthias
    Knight, Darryl A.
    Mutsaers, Steven E.
    INFLAMMATION RESEARCH, 2005, 54 : S101 - S101
12345